Blood markers for diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at two blood markers in people with diabetic kidney disease to see if they relate to the condition. It may help doctors understand the disease better and could lead to better monitoring or treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with diabetic nephropathy (kidney damage caused by diabetes).
- You are currently being evaluated or followed for diabetic kidney disease.
- You do not have liver disease, significant heart disease, cancer, blood clotting disorders, or a history of recent surgery.
- You are not taking medications that affect platelet function (like blood thinners).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
This study is looking at whether certain markers of inflammation in the blood can help detect or monitor kidney damage caused by type 2 diabetes. It compares these new markers with a well-known one (MCP-1) to see which might be more helpful for patients.
This study looks at whether two simple blood tests (a measure of insulin resistance and certain inflammation markers) can help predict how diabetic kidney disease will progress. If you have diabetes and early kidney problems, this might help your doctor better understand your condition.
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
This study looks at how the bacteria in your gut and certain blood markers might help predict changes in blood sugar levels for people with type 2 diabetes and kidney disease. The findings could lead to better ways to manage your condition and prevent complications.
Hear when a new Nephropathy, Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.